FR2355837A1 - NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS - Google Patents

NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Info

Publication number
FR2355837A1
FR2355837A1 FR7726295A FR7726295A FR2355837A1 FR 2355837 A1 FR2355837 A1 FR 2355837A1 FR 7726295 A FR7726295 A FR 7726295A FR 7726295 A FR7726295 A FR 7726295A FR 2355837 A1 FR2355837 A1 FR 2355837A1
Authority
FR
France
Prior art keywords
preparation
application
medicinal products
new prostaglandins
prostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7726295A
Other languages
French (fr)
Inventor
Roland Wenger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2355837A1 publication Critical patent/FR2355837A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne de nouvelles prostaglandines et leur préparation. Les composés de l'invention répondent à la formule :The invention relates to novel prostaglandins and their preparation. The compounds of the invention correspond to the formula:

FR7726295A 1976-04-27 1977-08-30 NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS Withdrawn FR2355837A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH526876 1976-04-27

Publications (1)

Publication Number Publication Date
FR2355837A1 true FR2355837A1 (en) 1978-01-20

Family

ID=4290745

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7706181A Withdrawn FR2353549A1 (en) 1976-04-27 1977-03-03 NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR7726295A Withdrawn FR2355837A1 (en) 1976-04-27 1977-08-30 NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7706181A Withdrawn FR2353549A1 (en) 1976-04-27 1977-03-03 NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Country Status (13)

Country Link
JP (1) JPS52131600A (en)
BE (1) BE852055A (en)
DE (1) DE2707915A1 (en)
DK (1) DK75177A (en)
FI (1) FI770572A (en)
FR (2) FR2353549A1 (en)
GB (1) GB1577647A (en)
IL (1) IL51561A0 (en)
NL (1) NL7702221A (en)
NZ (1) NZ183462A (en)
PT (1) PT66269B (en)
SU (1) SU741794A3 (en)
ZA (1) ZA771215B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds

Also Published As

Publication number Publication date
NZ183462A (en) 1979-10-25
DE2707915A1 (en) 1977-11-17
BE852055A (en) 1977-09-05
ZA771215B (en) 1978-10-25
JPS52131600A (en) 1977-11-04
GB1577647A (en) 1980-10-29
PT66269B (en) 1978-11-07
SU741794A3 (en) 1980-06-15
PT66269A (en) 1977-04-01
NL7702221A (en) 1977-10-31
DK75177A (en) 1977-10-28
FR2353549A1 (en) 1977-12-30
FI770572A (en) 1977-10-28
IL51561A0 (en) 1977-04-29

Similar Documents

Publication Publication Date Title
FR2398748A1 (en) NEW DERIVATIVES OF IMIDAZOQUINAZOLINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2390420A1 (en) NEW CYCLOPEPTIDIC DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2373513A1 (en) NEW NAPHTHALENE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2422634A1 (en) PGI2-TYPE 9-DESOXY-9A-METHYLENE ISOSTERS, USEFUL AS MEDICINAL PRODUCTS, AND PROCESS FOR PREPARATION
FR2430419A1 (en) NEW INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2391215A1 (en) NEW IMIDAZOAZINES AND IMIDAZODIAZINES, THEIR PREPARATION AND APPLICATION AS MEDICINAL PRODUCTS
FR2444681A1 (en) NOVEL 1,4-DIHYDROPYRIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2363556A1 (en) NEW PHENYLETHYLAMINES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
FR2436149A1 (en) NOVEL AMINOGLUCOSIDES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2398058A1 (en) NEW DERIVATIVES OF INDOLE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2445330A1 (en) DERIVATIVES OF 11-BROMO-14,15-DIOXO-E-HOMO-EBURNANE, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR2379533A1 (en) TETRAZOLYLCARBAMOYLQUINOLEINS FOR USE AS MEDICINAL PRODUCTS AND THEIR PREPARATION
FR2415636A1 (en) NEW GUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2370745A1 (en) NEW DERIVATIVES OF MORPHANTHRIDINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2375211A1 (en) NEW SULFAMOYLBENZOIC ACIDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2378015A1 (en) NEW DERIVATIVES OF BENZO (F) ISOQUINOLEINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2392011A1 (en) NEW 5-PHENYL-1H-3-BENZAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
FR2403341A1 (en) NEWS DIBENZO (A, D) CYCLOOCTENE, 5,12- (AND 6,12) -IMINES, THEIR PREPARATION AND THEIR APPLICATION AS A MEDICINAL PRODUCT
FR2365557A1 (en) NEW PERHYDRO-INDOLINOLS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2379532A1 (en) NEW DERIVATIVES OF OXAMIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2442236A1 (en)
FR2422647A1 (en) NEW 2,4-DIAMINO-5-BENZYLPYRIMIDINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2366289A1 (en) NEW DERIVATIVES OF IMIDAZO (5,1-A) ISOQUINOLEINE, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2355837A1 (en) NEW PROSTAGLANDINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2367765A1 (en) NEW QUINOLONES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS

Legal Events

Date Code Title Description
ST Notification of lapse